发现艾滋病毒25年后：治愈与疫苗的前景 - Suppr

Suppr

超能文献

25 years after HIV discovery: prospects for cure and vaccine.

作者信息

Montagnier Luc

机构信息

World Foundation AIDS Research and Prevention, UNESCO, Paris, France.

出版信息

Virology. 2010 Feb 20;397(2):248-54. doi: 10.1016/j.virol.2009.10.045.

DOI:10.1016/j.virol.2009.10.045

PMID:20152474

Abstract

摘要

相似文献

25 years after HIV discovery: prospects for cure and vaccine.

Virology. 2010 Feb 20;397(2):248-54. doi: 10.1016/j.virol.2009.10.045.

25 years of HIV.

Nature. 2008 May 15;453(7193):289-90. doi: 10.1038/453289a.

Policy watch. 25 years and counting.

AIDS Read. 2008 Jul;18(7):352-3.

Twenty years of therapy for HIV-1 infection.

Nat Med. 2003 Jul;9(7):867-73. doi: 10.1038/nm0703-867.

The chronicles of HIV therapeutics: where to begin, when to start and how will it end--a tale of two decades and beyond?

Can J Clin Pharmacol. 2002 Fall;9(3):120-2.

[25 years of the AIDS epidemic].

Tidsskr Nor Laegeforen. 2006 Nov 30;126(23):3140-4.

AIDS: the first 25 years.

AIDS Clin Care. 2006 Jun;18(6):53-4.

A reflection on HIV/AIDS research after 25 years.

Retrovirology. 2006 Oct 20;3:72. doi: 10.1186/1742-4690-3-72.

AIDS--the first 20 years.

N Engl J Med. 2001 Jun 7;344(23):1764-72. doi: 10.1056/NEJM200106073442306.

Antiretroviral drugs.

Curr Opin Pharmacol. 2010 Oct;10(5):507-15. doi: 10.1016/j.coph.2010.04.011. Epub 2010 May 12.

引用本文的文献

Taking the opportunity of COVID testing to screen vulnerable populations for hepatitis B, hepatitis C, syphilis, and human immunodeficiency virus in Central Brazil.

PLoS One. 2025 Jul 11;20(7):e0325859. doi: 10.1371/journal.pone.0325859. eCollection 2025.

HIV and Drug-Resistant Subtypes.

Microorganisms. 2023 Jan 15;11(1):221. doi: 10.3390/microorganisms11010221.

Myeloid-derived suppressor cells and vaccination against pathogens.

Front Cell Infect Microbiol. 2022 Sep 29;12:1003781. doi: 10.3389/fcimb.2022.1003781. eCollection 2022.

Inhibition by Marine Algae of Chikungunya Virus Isolated From Patients in a Recent Disease Outbreak in Rio de Janeiro.

Front Microbiol. 2019 Oct 24;10:2426. doi: 10.3389/fmicb.2019.02426. eCollection 2019.

A qualitative inquiry on the status and adequacy of legal instruments establishing infectious disease surveillance in Nigeria.

Pan Afr Med J. 2018 Sep 11;31:22. doi: 10.11604/pamj.2018.31.22.14119. eCollection 2018.

The Application of Humanized Mouse Models for the Study of Human Exclusive Viruses.

Methods Mol Biol. 2017;1656:1-56. doi: 10.1007/978-1-4939-7237-1_1.

Immunotherapy with an HIV-DNA Vaccine in Children and Adults.

Vaccines (Basel). 2014 Jul 17;2(3):563-80. doi: 10.3390/vaccines2030563.

Blood system changes since recognition of transfusion-associated AIDS.

Transfusion. 2013 Oct;53(10 Pt 2):2365-74. doi: 10.1111/trf.12373. Epub 2013 Aug 27.

Development of replication-competent viral vectors for HIV vaccine delivery.

Curr Opin HIV AIDS. 2013 Sep;8(5):402-11. doi: 10.1097/COH.0b013e328363d389.

HIV-1 protein induced modulation of primary human osteoblast differentiation and function via a Wnt/β-catenin-dependent mechanism.

J Orthop Res. 2013 Feb;31(2):218-26. doi: 10.1002/jor.22196. Epub 2012 Jul 31.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

25 years after HIV discovery: prospects for cure and vaccine.

Virology. 2010 Feb 20;397(2):248-54. doi: 10.1016/j.virol.2009.10.045.

25 years of HIV.

Nature. 2008 May 15;453(7193):289-90. doi: 10.1038/453289a.

Policy watch. 25 years and counting.

AIDS Read. 2008 Jul;18(7):352-3.

Twenty years of therapy for HIV-1 infection.

Nat Med. 2003 Jul;9(7):867-73. doi: 10.1038/nm0703-867.

The chronicles of HIV therapeutics: where to begin, when to start and how will it end--a tale of two decades and beyond?

Can J Clin Pharmacol. 2002 Fall;9(3):120-2.

[25 years of the AIDS epidemic].

Tidsskr Nor Laegeforen. 2006 Nov 30;126(23):3140-4.

AIDS: the first 25 years.

AIDS Clin Care. 2006 Jun;18(6):53-4.

A reflection on HIV/AIDS research after 25 years.

Retrovirology. 2006 Oct 20;3:72. doi: 10.1186/1742-4690-3-72.

AIDS--the first 20 years.

N Engl J Med. 2001 Jun 7;344(23):1764-72. doi: 10.1056/NEJM200106073442306.

Antiretroviral drugs.

Curr Opin Pharmacol. 2010 Oct;10(5):507-15. doi: 10.1016/j.coph.2010.04.011. Epub 2010 May 12.

引用本文的文献

Taking the opportunity of COVID testing to screen vulnerable populations for hepatitis B, hepatitis C, syphilis, and human immunodeficiency virus in Central Brazil.

PLoS One. 2025 Jul 11;20(7):e0325859. doi: 10.1371/journal.pone.0325859. eCollection 2025.

HIV and Drug-Resistant Subtypes.

Microorganisms. 2023 Jan 15;11(1):221. doi: 10.3390/microorganisms11010221.

Myeloid-derived suppressor cells and vaccination against pathogens.

Front Cell Infect Microbiol. 2022 Sep 29;12:1003781. doi: 10.3389/fcimb.2022.1003781. eCollection 2022.

Inhibition by Marine Algae of Chikungunya Virus Isolated From Patients in a Recent Disease Outbreak in Rio de Janeiro.

Front Microbiol. 2019 Oct 24;10:2426. doi: 10.3389/fmicb.2019.02426. eCollection 2019.

A qualitative inquiry on the status and adequacy of legal instruments establishing infectious disease surveillance in Nigeria.

Pan Afr Med J. 2018 Sep 11;31:22. doi: 10.11604/pamj.2018.31.22.14119. eCollection 2018.

The Application of Humanized Mouse Models for the Study of Human Exclusive Viruses.

Methods Mol Biol. 2017;1656:1-56. doi: 10.1007/978-1-4939-7237-1_1.

Immunotherapy with an HIV-DNA Vaccine in Children and Adults.

Vaccines (Basel). 2014 Jul 17;2(3):563-80. doi: 10.3390/vaccines2030563.

Blood system changes since recognition of transfusion-associated AIDS.

Transfusion. 2013 Oct;53(10 Pt 2):2365-74. doi: 10.1111/trf.12373. Epub 2013 Aug 27.

Development of replication-competent viral vectors for HIV vaccine delivery.

Curr Opin HIV AIDS. 2013 Sep;8(5):402-11. doi: 10.1097/COH.0b013e328363d389.

HIV-1 protein induced modulation of primary human osteoblast differentiation and function via a Wnt/β-catenin-dependent mechanism.

J Orthop Res. 2013 Feb;31(2):218-26. doi: 10.1002/jor.22196. Epub 2012 Jul 31.